ABBOTT LABORATORIES

Pharmaceutical Preparations·ABBOTT PARK, IL·FY end 12/31·CIK 1800

CEO Pay Ratio

166:1

Robert B. Ford

CEO Total Comp

$24.2M

Robert B. Ford

Median Employee

$145,528

Revenue

$44.3B

FY 2025

Net Income

$6.5B

FY 2025

Free Cash Flow

$7.4B

FY 2025

Net Margin

14.7%

Insider Net (180d)

$775.2K

2 buys / 4 sales

CEO Pay Accountability

CEO comp as % of net income

0.37%

For every $1,000 of profit, $3.71 flows to the CEO.

CEO comp as % of buybacks

2.71%

CEO comp equals 27.1‰ of cash returned to shareholders via buybacks.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$44.3B	$42.0B	$40.1B	$43.7B	$43.1B
Gross Profit	—	—	—	—	—	—
Operating Income	$8.1B	$6.8B	$6.5B	$8.4B	$8.4B
Net Income	$6.5B	$13.4B	$5.7B	$6.9B	$7.1B
Operating CF	$9.6B	$8.6B	$7.3B	$9.6B	$10.5B
Capex	$2.2B	$2.2B	$2.2B	$1.8B	$1.9B
Free Cash Flow	$7.4B	$6.4B	$5.1B	$7.8B	$8.6B
Buybacks	$893.0M	$1.3B	$1.2B	$3.8B	$2.3B
Dividends	$4.1B	$3.8B	$3.6B	$3.3B	$3.2B

Gross Margin	—	—	—	—	—	—
Operating Margin	18.2%	16.3%	16.2%	19.2%	19.6%
Net Margin	14.7%	31.9%	14.3%	15.9%	16.4%
FCF Margin	16.7%	15.1%	12.6%	17.9%	20.1%
R&D / Revenue	6.6%	6.8%	6.8%	6.6%	6.4%
Effective Tax	22.9%	-91.1%	14.1%	16.5%	13.9%
Debt / Equity	0.44	0.56	0.73	0.85	0.99
Buybacks / FCF	12.1%	20.4%	24.3%	48.6%	26.6%

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Robert B. Ford Chairman of the Board and Chief Executive Officer	$1.5M	$8.8M	$8.8M	$2.0M	$3.2M	$24.2M
Philip P. Boudreau Executive Vice President, Finance and Chief Financial Officer	$974.2K	$3.0M	$3.0M	$1.1M	$968.7K	$9.1M
Lisa D. Earnhardt Executive Vice President and Group President, Medical Devices	$924.2K	$2.5M	$2.5M	$1.3M	$773.7K	$8.1M
Christopher J. Scoggins Executive Vice President, Diabetes Care	$859.5K	$1.7M	$1.7M	$1.1M	$1.3M	$6.6M
Daniel G. Salvadori Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$924.2K	$2.2M	$2.2M	$388.2K	$744.0K	$6.5M